NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS
Histological analysis of endomyocardial tissue is still the gold standard for the diagnosis of cardiac amyloidosis but has its limitations. Accordingly, there is a need for noninvasive techniques to cardiac amyloidosis diagnostics. Echocardiography and magnetic resonance imaging can show characteris...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2018-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1624 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227640768036864 |
|---|---|
| author | V. B. Sergienko S. N. Tereshchenko A. A. Ansheles I. V. Zhirov A. A. Safiullina |
| author_facet | V. B. Sergienko S. N. Tereshchenko A. A. Ansheles I. V. Zhirov A. A. Safiullina |
| author_sort | V. B. Sergienko |
| collection | DOAJ |
| description | Histological analysis of endomyocardial tissue is still the gold standard for the diagnosis of cardiac amyloidosis but has its limitations. Accordingly, there is a need for noninvasive techniques to cardiac amyloidosis diagnostics. Echocardiography and magnetic resonance imaging can show characteristics which may not be very specific for cardiac amyloid. Recently, new opportunities of nuclear imaging in risk stratification and assessment of prognosis for patients with cardiac amyloidosis have appeared. During the last two decades different classes of radiopharmaceuticals have been developed based on compounds tropic to the components of amyloid infiltrates. In this paper we describe the current possibilities and perspectives of nuclear medicine techniques in patients with cardiac amyloidosis, including osteotropic and neurotropic scintigraphy, single-photon and positron emission tomography |
| format | Article |
| id | doaj-art-3d003d6473834e6fbd65b1bbc394e311 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2018-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-3d003d6473834e6fbd65b1bbc394e3112025-08-23T10:00:29ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532018-03-011419410010.20996/1819-6446-2018-14-1-94-1001452NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSISV. B. Sergienko0S. N. Tereshchenko1A. A. Ansheles2I. V. Zhirov3A. A. Safiullina4National Medical Research Center of CardiologyNational Medical Research Center of CardiologyNational Medical Research Center of CardiologyNational Medical Research Center of CardiologyNational Medical Research Center of CardiologyHistological analysis of endomyocardial tissue is still the gold standard for the diagnosis of cardiac amyloidosis but has its limitations. Accordingly, there is a need for noninvasive techniques to cardiac amyloidosis diagnostics. Echocardiography and magnetic resonance imaging can show characteristics which may not be very specific for cardiac amyloid. Recently, new opportunities of nuclear imaging in risk stratification and assessment of prognosis for patients with cardiac amyloidosis have appeared. During the last two decades different classes of radiopharmaceuticals have been developed based on compounds tropic to the components of amyloid infiltrates. In this paper we describe the current possibilities and perspectives of nuclear medicine techniques in patients with cardiac amyloidosis, including osteotropic and neurotropic scintigraphy, single-photon and positron emission tomographyhttps://www.rpcardio.online/jour/article/view/1624cardiac amyloidosisradionuclide diagnosticsal-amyloidosisaa-amyloidosisattramyloidosisaanfamyloidosismeta-iodobenzyl guanidinesingle photon emission computerized tomographypositron emission tomography |
| spellingShingle | V. B. Sergienko S. N. Tereshchenko A. A. Ansheles I. V. Zhirov A. A. Safiullina NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS Рациональная фармакотерапия в кардиологии cardiac amyloidosis radionuclide diagnostics al-amyloidosis aa-amyloidosis attramyloidosis aanfamyloidosis meta-iodobenzyl guanidine single photon emission computerized tomography positron emission tomography |
| title | NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS |
| title_full | NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS |
| title_fullStr | NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS |
| title_full_unstemmed | NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS |
| title_short | NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS |
| title_sort | nuclear imaging in the diagnosis of cardiac amyloidosis |
| topic | cardiac amyloidosis radionuclide diagnostics al-amyloidosis aa-amyloidosis attramyloidosis aanfamyloidosis meta-iodobenzyl guanidine single photon emission computerized tomography positron emission tomography |
| url | https://www.rpcardio.online/jour/article/view/1624 |
| work_keys_str_mv | AT vbsergienko nuclearimaginginthediagnosisofcardiacamyloidosis AT sntereshchenko nuclearimaginginthediagnosisofcardiacamyloidosis AT aaansheles nuclearimaginginthediagnosisofcardiacamyloidosis AT ivzhirov nuclearimaginginthediagnosisofcardiacamyloidosis AT aasafiullina nuclearimaginginthediagnosisofcardiacamyloidosis |